Isturisa Tablet, Coated
Product Images NDC 55292-321

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Isturisa (NDC 55292-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Isturisa 01)

Chemical structure of the active ingredient in Isturisa, showing a fused ring system with an imidazole moiety, a fluorobenzene ring substituted with a cyano group, and a phosphate counterion (H2PO4-). This structural diagram highlights the molecular arrangement relevant to the drug Isturisa by Recordati Rare Diseases, Inc.*

FDA Label Image

Principal Display Panel (1 mg Blister Pack Carton)

Isturisa 1 mg tablets packaging label for oral use, containing osilodrostat as the active ingredient. The label indicates the product is supplied in a carton of 60 film-coated tablets, manufactured for Recordati Rare Diseases, Inc. The label includes storage instructions, a barcode, and the NDC 55292-330-60.*

FDA Label Image

Principal Display Panel (5 mg Blister Pack Carton)

Isturisa 5 mg tablets packaging label by Recordati Rare Diseases, Inc. The label includes the proprietary name Isturisa with the active ingredient osilodrostat and strength of 5 mg. It states the quantity as 60 film-coated tablets and includes storage instructions, usage for oral administration, and a barcode. The design features a green vertical stripe and the Recordati Rare Diseases logo.*

FDA Label Image

Principal Display Panel (1 mg Blister Pack Carton)

Packaging label for Isturisa 1 mg tablets (osilodrostat) by Recordati Rare Diseases, Inc. The label shows the product name and strength prominently with instructions for oral use and storage conditions. It states 60 film-coated tablets per package and includes the NDC 55292-320-60.*

FDA Label Image

Principal Display Panel (5 mg Blister Pack Carton)

Packaging label for Isturisa 5 mg tablets (osilodrostat) manufactured by Recordati Rare Diseases, Inc. The label indicates the product contains 60 film-coated tablets with 5 mg osilodrostat each. It includes storage instructions, prescribing information reference, and a contact number for more information.*

FDA Label Image

Principal Display Panel (10 mg Blister Pack Carton)

Packaging label for Isturisa 10 mg tablets (osilodrostat) manufactured by Novartis Pharma Stein AG and distributed by Recordati Rare Diseases, Inc. The label shows the product name, strength, dosage form, NDC 55292-322-60, quantity of 60 film-coated tablets, and storage instructions. The labeler is Recordati Rare Diseases, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.